Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Lexeo Therapeutics (LXEO) Other Operating Expenses (2023)

Lexeo Therapeutics' Other Operating Expenses history spans 2 years, with the latest figure at -$1000.0 for Q4 2023.

  • For Q4 2023, Other Operating Expenses changed N/A year-over-year to -$1000.0; the TTM value through Sep 2023 reached $1000.0, changed N/A, while the annual FY2024 figure was -$18.5 million, 94.69% down from the prior year.
  • Other Operating Expenses for Q4 2023 was -$1000.0 at Lexeo Therapeutics, down from $1000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $15.4 million in Q3 2022 and bottomed at -$1000.0 in Q4 2023.